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Malformation of the atrioventricular (AV) cushion is a common congenital heart
defect. Ebstein’s anomaly, characterized by a heart defect related to the AV
cushion, involves not only a valve defect but also a myocardial abnormality such
as Uhl’s anomaly. The morphogenetic features of the heart in the case of these
diseases can be used as a reference for investigating valvuloseptal and
myocardial formations in the human heart.
The AV endocardium transforms into the cushion mesenchyme through
epithelial–mesenchymal transition (EMT). After the EMT, distal outgrowth
and maturation of endocardial cushions are important morphogenetic steps for
AV valvuloseptal morphogenesis. While bone morphogenetic protein (BMP)-
2 is known to be critical for AV EMT, little is known about the functional
relationship between BMP and ECM and their roles in cushion mesenchymal
cell (CMC) migration after EMT. In our previous study, we showed that BMP-2
and BMP signaling induced AV CMC migration. We have been exploring the
role of BMP-2 in the regulation of valvulogenic extracellular matrix (ECM)
components, periostin, versican, and hyaluronic acid (HA), and cell migration
during post-EMT AV cushion expansion and maturation.
We further examined whether BMP-2-promoted cell migration is associated
with expression of periostin, versican, and HA. BMP-2-promoted cell migration
is significantly impaired by treatment with versican siRNA and HA oligomer.
We also found that transcription of Twist and Id1, implicated in cell migration in
embryogenesis and activation of the periostin promoter, was induced by BMP-2
but repressed by noggin in CMC cultures.
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Taken together, we provide evidence that BMP-2 induces expression and
deposition of three major ECM proteins, periostin, versican, and HA, and that
these ECM components contribute to BMP-2-induced CMC migration during
post-EMT AV cushion expansion and maturation.
Based on these findings, we discuss the morphogenetic process of AV valve
abnormalities and crosstalk between valve and cardiomyocytes morphogenesis.
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17.1 Introduction
Our institute houses a huge amount of congenital heart disease specimens, of which
approximately 4,000 are referred to as Prof. Ando’s collections, and the late
Dr. Ando, former professor at our department, wrote 30 books describing the
anatomical features of the specimens.
In one of the books, I read the following text at the edge of a page: “I think there
is a right ventricle (RV)–tricuspid valve (TV) dysplastic syndrome as a new clinical
entity, which comprises three abnormalities, Ebstein’s anomaly, Uhl’s anomaly,
and tricuspid absence.” This note can be likened to the one written by Fermat, on
the basis of which Fermat’s son Cle´ment-Samuel deduced Fermat’s last theorem
(Fig. 17.1).
Tricuspid valve anomalies syndrome
Ebstein Disease
Uhl’s anomaly TV absence




anomaly and tricuspid valve
absence sometimes coexist in
a heart
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17.2 RV–TV Dysplastic Syndrome
17.2.1 Anatomic Features of the Heart in Ebstein’s Anomaly
Patients
Ebstein’s anomaly is a rare congenital cardiac disease in which the TV leaflets are
displaced to the right ventricular cavity, resulting in atrialization of the RV
[1]. Marked right atrial enlargement caused by severe tricuspid insufficiency,
cardiomegaly, and increased right atrial pressure; cyanosis caused by right–left
shunt by way of interatrial communication, if present; and right ventricular volume
overload are often observed. Figure 17.2 illustrates Ebstein’s anomaly with severe
TV insufficiency involving two-thirds of the RV.
17.2.2 Morphogenetic Features of the Heart in Patients with Uhl’s
Anomaly
In the case of patients with Ebstein’s anomaly, the RV of the heart often shows
partial or total loss of myocardium; in other words, the features of Ebstein’s
anomaly overlap those of Uhl’s anomaly. Uhl’s anomaly, a rare congenital heart
disease characterized by the absence of apical trabeculations in the right ventricular
cavity with a thin hypokinetic ventricular wall, was first described in 1952 [2]. In
Fig. 17.3, almost complete absence of the right ventricular myocardium, preserved
septum, and left ventricular myocardium is seen. These clinical and anatomic
findings strongly indicate that AV valve formation and ventricular myocardium
formation may play a role during cardiac morphogenesis.
RVOT
Fig. 17.2 Ebstein’s anomaly
with severe TV plastering
down into two thirds of right
ventricle (RV). The cushion
tissue plastered almost
throughout RV with a
something like plaster and it
looks very smooth surface
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17.2.3 Absence of the TV
Unguarded TV orifice is an unusual cardiac malformation that involves partial or
total agenesis of the TV tissue (absence of the TV). Kanjuh et al. described the
anatomic features of the heart in this disease: the wall of the RV is formed by
slightly trabeculated muscle and lined by thickened endocardium [3]; the free wall
of the RV is only 2 mm thick, and the ventricular septum is intact. In Fig. 17.4, the
specimen shows TV absence and partial loss of the right ventricular myocardium.
TV–RV dysplastic syndrome revealed the important link between TV morpho-
genesis and right ventricular myocardium formation during the biological process
of cardiac morphogenesis. Therefore, it is vital to determine the biological key
factors that link the myocardium and cushion tissue.
17.3 Bone Morphogenetic Proteins (BMPs) and Their Important
Role in Cushion Formation
17.3.1 Role of BMP2 in Cushion Mesenchymal Cell (CMC) Migration
Anomalies related to valvuloseptal formation are some of the most common
congenital heart anomalies. Two segments of the endocardium, the atrioventricular
(AV) and outflow tract (OT) endocardium, transform into the cushion mesen-
chyme—the primordia of the valves and membranous septa—through epithelial–
mesenchymal transformation (EMT). Transformed endocardial cells subsequently
migrate to the underlying extracellular matrix (ECM), called “cardiac jelly,” and
remodel the ECM into cardiac cushions [4]. Distal outgrowth and maturation of the




Fig. 17.3 Ebstein’s anomaly
with Uhl’s anomaly. Note the
complete absence of the right
ventricular myocardium and
preserved septal and left
ventricular myocardium
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BMP is a member of the TGF-ß superfamily proteins, one of many molecules
related to AV EMT. BMP signaling was found to be crucial for AV EMT in studies
involving explant cultures in mice and chicks and BMP-2 conditional knockout
(CKO) experiments in mice [5]. BMP-2 conditional KO at the EMT stage, however,
causes subsequent lethality, thereby hindering the examination of the role of
BMP-2 in post-EMT valve formation. BMPs bind to the cell surface of BMP
receptors (BMPRs)—Type I and Type II receptors. Type II receptors transpho-
sphorylate the glycine–serine-rich domain of Type I receptors and transduce intra-
cellular signals. The Type II BMP receptor, BMPRII, is reported to be expressed
ubiquitously throughout the embryonic period [6].
We previously showed the expression patterns of Type I BMPRs by localizing
BMPR-1A (ALK3), BMPR-1B (ALK6), and ALK2 in the post-EMT AV cushion
mesenchyme in a chick. These findings indicate that BMP signaling regulates the
biological processes necessary for distal outgrowth and maturation of post-EMT
cushion mesenchyme during early valvulogenesis [4].
17.3.2 BMP2 Induces CMC Migration and Id and Twist Expression
BMP-2 is localized in the AV cushion mesenchyme during post-EMT valve forma-
tion, suggesting autocrine signaling by BMP-2 in CMCs during post-EMT valve
formation. Therefore, to determine the roles of BMP-2 and BMP signaling in
post-EMT AV CMCs, we established a hanging-drop culture system and spatiotem-
poral viral gene-transfer technique using chick AV CMC cultures both in vitro and
RA
Hypoplastic RV
Fig. 17.4 Ebstein’s anomaly with tricuspid valve absence and Uhl’s anomaly. Unguarded
tricuspid valve orifice and partial absence of the right ventricular myocardium concomitant with
Ebstein’s anomaly. Note the absence of the rudimentum of the tricuspid valve and tension
apparatus
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whole embryo cultures in vivo (ovo) [5]. Although most BMP receptors have ligand-
binding affinity with other TGF-ß superfamily proteins, BMPR-1A and BMPR-1B
bind specifically with BMP-2 and BMP-4 (bind with BMP-7 at low affinity) but do
not bind with other TGF-ß superfamily proteins. We showed that dnBMPR-1B
infection as well as treatment with a BMP antagonist, noggin, significantly inhibited
endogenous phospho-Smad 1/5/8 expression in AV CMCs, indicating that intracel-
lular BMP signaling in the CMCs is effectively inhibited by treatment with dnBMPR-
1B or noggin. On the other hand, BMP-2 or caBMPR-1B-virus treatment induced






Fig. 17.5 AV cushions were microinjected with caBMPR-1B virus (a) or dnBMPR-1B virus.
Cushion mesenchyme microinjected with dnBMPR-1B virus showed a significant decrease in
periostin immunostaining (red colour in b). Conversely, infection with caBMPR-1B virus showed
significant increase periostin expression in cushion mesencyme (red colour in a). High magnifica-
tion view of virus-infected cushion mesenchyme (c and d). In the caBMPR-1B infected cushion,
there was extensive overlapping of viral marker expression (green) and periostin expression (red)
(yellow arrows in c). Although periostin staining (red) was detected in the dnBMPR-1B infected
cushion, there was little overlapping of periostin expression (red) and viral marker expression
(green arrows in d)
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effectively intensified by BMP-2 or caBMPR-1B. Based on these findings, it can be
said that the effects of dnBMPR-1B treatment on CMC migration and phosphor-
Smad1/5/8 expression are as profound as the effects of noggin treatment. Moreover,
caBMPR-1B treatment enhances CMC migration as much as BMP2 treatment does
(Fig. 17.5). These facts strongly suggest that BMP signaling plays an important role
in mesenchymal cell migration after EMT.We also showed that expressions of Id and
Twist-1, which are important transcriptional factors involved in cell migration, are
enhanced by BMP signaling [4].
17.3.3 BMP2 Induces Expression of ECM Proteins in the Post-EMT
Cushion
We showed the expression patterns of three major ECM components, periostin,
versican, and hyaluronic acid (HA), during AV cushion expansion and maturation.
We also elucidated the role of BMP2 in the production of periostin, versican, and
HA. Using a well-defined 3D CMC aggregate by hanging-drop culture on hydrated
collagen gels, we found that BMP2 induces production of periostin, versican, and
HA and that these ECM components contribute to BMP2-supported CMC migra-
tion during post-EMT cushion expansion and maturation [7].
Taken together, BMP signaling plays a critical role for AV cushion formation
and AV valve maturation.
17.4 The Role of BMP2 for Cardiomyocytes Formation
It is well known that the BMP signaling pathway plays a central role in
cardiomyogenesis [8–10]. In the past, it was found that administration of BMP-2
counteracts apoptosis of neonatal cardiomyocytes in culture, induced by serum
starvation [9]. Moreover, BMP10 expression is restricted to cardiomyocytes in the
developing and postnatal heart. Ligands of BMP10 have specificity for ALK1,
ALK6, and BMPR2 receptors. Global disruption of BMP10 is embryonic lethal
with severely impaired cardiomyocyte proliferative capacity [11]. BMP2 and
BMP10 appear to control cardiomyocyte differentiation through activation of
transcription factors NKX2.5, MEF2C, and TBX20 [12].
Chakraborty et al. reported that cardiomyocyte-specific Tbx20 overexpression
beginning in the fetal period is sufficient for promoting cardiomyocyte
proliferation [12].
Therefore, BMP signaling plays special role in linking AV cushion and
cardiomyocyte formation.
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17.5 Future Direction
At present, many aspects of the molecular mechanisms underlying RV–TV dys-
plastic syndrome remain to be elucidated. To fully describe the morphogenetic
mechanisms underlying TV–RV dysplastic syndrome, we need to determine the
molecular mechanisms underlying the interaction between TV and RV myocar-
dium through BMP signaling. Moreover, we need to outline the steps involved in
cardiac valve and myocardium morphogenesis.
What is the next target molecule? Here, I would like to discuss about the
potential of the “Notch” signaling pathway. The Notch signaling pathway plays
multiple roles in cardiac morphogenesis, including regulation of valve formation,
outflow tract development, and cardiac chamber maturation [13]. Notch activation
is upstream of ephrin- and neuregulin-based modulation of trabeculation and
BMP-2 and BMP-10 modulation of cardiomyocyte proliferation. Consistent with
the involvement of Notch signaling in multiple aspects of cardiac development,
components of the Notch pathway show dynamic spatial and temporal expression
patterns in the developing vertebrate heart, and both endocardial and myocardial
expression have been observed. Furthermore, the cross reaction between NOTCH
and BMP signaling is a well-known fact [14]. Therefore, understanding the com-
plicity of these signaling pathways is imperative for elucidating the relationship
between cardiac valve and myocardium formation.
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